GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Invent Medic Sweden AB (XSAT:IMS) » Definitions » EV-to-EBIT

Invent Medic Sweden AB (XSAT:IMS) EV-to-EBIT : -3.09 (As of Mar. 04, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Invent Medic Sweden AB EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Invent Medic Sweden AB's Enterprise Value is kr19.19 Mil. Invent Medic Sweden AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was kr-6.22 Mil. Therefore, Invent Medic Sweden AB's EV-to-EBIT for today is -3.09.

The historical rank and industry rank for Invent Medic Sweden AB's EV-to-EBIT or its related term are showing as below:

XSAT:IMS' s EV-to-EBIT Range Over the Past 10 Years
Min: -18.9   Med: -3.5   Max: 0.09
Current: -3.09

During the past 9 years, the highest EV-to-EBIT of Invent Medic Sweden AB was 0.09. The lowest was -18.90. And the median was -3.50.

XSAT:IMS's EV-to-EBIT is ranked worse than
100% of 453 companies
in the Medical Devices & Instruments industry
Industry Median: 19.13 vs XSAT:IMS: -3.09

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Invent Medic Sweden AB's Enterprise Value for the quarter that ended in Dec. 2024 was kr12.67 Mil. Invent Medic Sweden AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was kr-6.22 Mil. Invent Medic Sweden AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was -49.04%.


Invent Medic Sweden AB EV-to-EBIT Historical Data

The historical data trend for Invent Medic Sweden AB's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invent Medic Sweden AB EV-to-EBIT Chart

Invent Medic Sweden AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only -6.09 -1.04 -1.73 -3.23 -2.04

Invent Medic Sweden AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.23 -3.39 -3.40 -1.90 -2.04

Competitive Comparison of Invent Medic Sweden AB's EV-to-EBIT

For the Medical Devices subindustry, Invent Medic Sweden AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invent Medic Sweden AB's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Invent Medic Sweden AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Invent Medic Sweden AB's EV-to-EBIT falls into.



Invent Medic Sweden AB EV-to-EBIT Calculation

Invent Medic Sweden AB's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=19.192/-6.215
=-3.09

Invent Medic Sweden AB's current Enterprise Value is kr19.19 Mil.
Invent Medic Sweden AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-6.22 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Invent Medic Sweden AB  (XSAT:IMS) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Invent Medic Sweden AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2024 ) =EBIT / Enterprise Value (Q: Dec. 2024 )
=-6.215/12.672628
=-49.04 %

Invent Medic Sweden AB's Enterprise Value for the quarter that ended in Dec. 2024 was kr12.67 Mil.
Invent Medic Sweden AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-6.22 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Invent Medic Sweden AB EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Invent Medic Sweden AB's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Invent Medic Sweden AB Business Description

Traded in Other Exchanges
N/A
Address
Nytenkargatan 4, Lund, SWE, 223 63
Invent Medic Sweden AB develops and markets its product - Efemia bladder support, a vaginal medical device for the treatment of female urinary incontinence.

Invent Medic Sweden AB Headlines

From GuruFocus

5 Companies Reach 52-Week Highs

By yifan900 yifan900 02-13-2018

Healthcare Informatics: A Value Investor's Perspective

By Thomas Macpherson Thomas Macpherson 10-23-2015

The Big 3: Larry Robbins' Top 2nd-Quarter Buys

By James Li James Li 08-16-2016

Weekly Insider Sells Highlight: IMS, NOW, BMY, EA

By James Xiao James Xiao 08-11-2015

Well-Known Companies Reach 52 Week Highs

By yifan900 yifan900 10-11-2016